Back to ELVN

Spruce Street Capital LP → ELVN

Spruce Street Capital LP ELVN Position History

Enliven Therapeutics, Inc. • Healthcare

Quarters held
4
Latest value
$15.1M
Q3 2026
Peak value
$16.7M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$6.9M
Q1 2026$12.9M
Q2 2026$16.7M
Q3 2026$15.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$15.1M329.0K——
Q2 2026$16.7M329.0K——
Q1 2026$12.9M329.0K——
Q4 2025$6.9M446.1K——

Other funds holding ELVN

Other Spruce Street Capital LP positions

KNSA

KINIKSA PHARMACEUTICALS INTL

$68.5M
KNSA

KINIKSA PHARMACEUTICALS INTL

$58.7M
RLAY

RELAY THERAPEUTICS INC

$55.8M
RLAY

RELAY THERAPEUTICS INC

$53.9M
LBRX

LB PHARMACEUTICALS INC

$53.9M
LBRX

LB PHARMACEUTICALS INC

$44.7M
RLMD

RELMADA THERAPEUTICS INC

$44.2M
RLMD

RELMADA THERAPEUTICS INC

$43M